These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8718582)

  • 1. New vaccines against bacterial toxins.
    Rappuoli R; Pizza M; Douce G; Dougan G
    Adv Exp Med Biol; 1996; 397():55-60. PubMed ID: 8718582
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic detoxification of bacterial toxins: a new approach to vaccine development.
    Rappuoli R; Douce G; Dougan G; Pizza M
    Int Arch Allergy Immunol; 1995 Dec; 108(4):327-33. PubMed ID: 7580303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial toxin vaccines.
    McDonel JL
    Adv Biotechnol Processes; 1990; 13():1-33. PubMed ID: 2110461
    [No Abstract]   [Full Text] [Related]  

  • 4. Rational design of vaccines.
    Rappuoli R
    Nat Med; 1997 Apr; 3(4):374-6. PubMed ID: 9095163
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pathogenetic significance of Bordetella pertussis toxin].
    Finger H
    Immun Infekt; 1985 Apr; 13(2):47-9. PubMed ID: 2860059
    [No Abstract]   [Full Text] [Related]  

  • 6. [Development of new generation of vaccine against pertussis, cholera, botulism, tetanus, and diphtheria toxins].
    Ivanov KK
    Mol Gen Mikrobiol Virusol; 1993; (2):3-9. PubMed ID: 8515748
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of pertactin in pertussis vaccines: the jury is still out.
    Desauziers E; Danve B; Decker MD; Veitch K
    J Infect Dis; 2004 Apr; 189(7):1332-3; author reply 1333-5. PubMed ID: 15031804
    [No Abstract]   [Full Text] [Related]  

  • 8. Filamentous hemagglutinin and pertussis toxin from Bordetella pertussis modulate immune responses to unrelated antigens.
    McGuirk P; Johnson PA; Ryan EJ; Mills KH
    J Infect Dis; 2000 Oct; 182(4):1286-9. PubMed ID: 10979938
    [No Abstract]   [Full Text] [Related]  

  • 9. Current Progress in Developing Subunit Vaccines against Enterotoxigenic Escherichia coli-Associated Diarrhea.
    Zhang W; Sack DA
    Clin Vaccine Immunol; 2015 Sep; 22(9):983-91. PubMed ID: 26135975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A tripartite fusion, FaeG-FedF-LT(192)A2:B, of enterotoxigenic Escherichia coli (ETEC) elicits antibodies that neutralize cholera toxin, inhibit adherence of K88 (F4) and F18 fimbriae, and protect pigs against K88ac/heat-labile toxin infection.
    Ruan X; Liu M; Casey TA; Zhang W
    Clin Vaccine Immunol; 2011 Oct; 18(10):1593-9. PubMed ID: 21813665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial toxin vaccines.
    Dorner F; McDonel JL
    Vaccine; 1985 Jun; 3(2):94-102. PubMed ID: 3929492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Escherichia coli K88ac fimbriae expressing heat-labile and heat-stable (STa) toxin epitopes elicit antibodies that neutralize cholera toxin and STa toxin and inhibit adherence of K88ac fimbrial E. coli.
    Zhang C; Zhang W
    Clin Vaccine Immunol; 2010 Dec; 17(12):1859-67. PubMed ID: 20980482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutants of Escherichia coli heat-labile toxin act as effective mucosal adjuvants for nasal delivery of an acellular pertussis vaccine: differential effects of the nontoxic AB complex and enzyme activity on Th1 and Th2 cells.
    Ryan EJ; McNeela E; Murphy GA; Stewart H; O'hagan D; Pizza M; Rappuoli R; Mills KH
    Infect Immun; 1999 Dec; 67(12):6270-80. PubMed ID: 10569737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant.
    Holmgren J; Bourgeois L; Carlin N; Clements J; Gustafsson B; Lundgren A; Nygren E; Tobias J; Walker R; Svennerholm AM
    Vaccine; 2013 May; 31(20):2457-64. PubMed ID: 23541621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant enterotoxins as vaccines against Escherichia coli-mediated diarrhoea.
    Aitken R; Hirst TR
    Vaccine; 1993; 11(2):227-33. PubMed ID: 8438620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic fusions of heat-labile toxoid (LT) and heat-stable toxin b (STb) of porcine enterotoxigenic Escherichia coli elicit protective anti-LT and anti-STb antibodies.
    Zhang W; Francis DH
    Clin Vaccine Immunol; 2010 Aug; 17(8):1223-31. PubMed ID: 20505006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal antibody response after oral immunization with a prototype cholera B subunit-colonization factor antigen enterotoxigenic Escherichia coli vaccine.
    Ahrén C; Wennerås C; Holmgren J; Svennerholm AM
    Vaccine; 1993; 11(9):929-34. PubMed ID: 8212839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in the development of pertussis vaccines.
    Brennan MJ; Burns DL; Meade BD; Shahin RD; Manclark CR
    Biotechnology; 1992; 20():23-52. PubMed ID: 1600382
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibody responses after vaccination and disease against leukocytosis promoting factor, filamentous hemagglutinin, lipopolysaccharide and a protein binding to complement-fixing antibodies induced during whooping cough.
    Winsnes R; Lønnes T; Møgster B; Berdal BP
    Dev Biol Stand; 1985; 61():353-65. PubMed ID: 2872124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum IgG antibody response to pertussis toxin in persons for whom pertussis vaccination failed depends upon the number of antigens in the vaccine.
    Cherry JD
    Clin Infect Dis; 1999 Mar; 28(3):560-1. PubMed ID: 10194078
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.